- Elon Musk’s neurotechnology startup, Neuralink, is recruiting for its first human trial.
- The FDA granted the company approval for human testing in May 2023 after rejecting its application last year, citing safety concerns.
- Neuralink will test the safety and feasibility of its brain implant, and it hopes to help patients with paralysis control a keyboard or computer cursor with their minds.
Elon Musk’s biotechnology startup, Neuralink, recently announced that it’s recruiting volunteers for its first human trial of brain implants for patients with paralysis.
The company said on X that people who have quadriplegia (both arms and legs are paralyzed) due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) may qualify.
During the trial, a surgical robot will place a brain-computer interface (BCI) impact in the part of the brain that controls movement intention. The goal is for people with paralysis to control a keyboard or computer cursor with their minds, according to a Neuralink blog post.